<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Associations between <z:chebi fb="19" ids="27568">selenium</z:chebi> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> have directed attention to role of selenoproteins in the carcinogenic process </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We used data from two population-based case-control studies of colon (n = 1555 cases, 1956 controls) and rectal (n = 754 cases, 959 controls) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the association between genetic variation in TXNRD1, TXNRD2, TXNRD3, C11orf31 (SelH), SelW, SelN1, SelS, SepX, and SeP15 with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: After adjustment for multiple comparisons, several associations were observed </plain></SENT>
<SENT sid="4" pm="."><plain>Two SNPs in TXNRD3 were associated with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (rs11718498 dominant OR 1.42 95% CI 1.16,1.74 pACT 0.0036 and rs9637365 recessive 0.70 95% CI 0.55,0.90 pACT 0.0208) </plain></SENT>
<SENT sid="5" pm="."><plain>Four SNPs in SepN1 were associated with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (rs11247735 recessive OR 1.30 95% CI 1.04,1.63 pACT 0.0410; rs2072749 GGvsAA OR 0.53 95% CI 0.36,0.80 pACT 0.0159; rs4659382 recessive OR 0.58 95% CI 0.39,0.86 pACT 0.0247; rs718391 dominant OR 0.76 95% CI 0.62,0.94 pACT 0.0300) </plain></SENT>
<SENT sid="6" pm="."><plain>Interaction between these genes and exposures that could influence these genes showed numerous significant associations after adjustment for multiple comparisons </plain></SENT>
<SENT sid="7" pm="."><plain>Two SNPs in TXNRD1 and four SNPs in TXNRD2 interacted with aspirin/<z:chebi fb="1" ids="35475">NSAID</z:chebi> to influence <z:hpo ids='HP_0003003'>colon cancer</z:hpo>; one SNP in TXNRD1, two SNPs in TXNRD2, and one SNP in TXNRD3 interacted with aspirin/<z:chebi fb="1" ids="35475">NSAIDs</z:chebi> to influence <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Five SNPs in TXNRD2 and one in SelS, SeP15, and SelW1 interacted with <z:chebi fb="0" ids="50114">estrogen</z:chebi> to modify <z:hpo ids='HP_0003003'>colon cancer</z:hpo> risk; one SNP in SelW1 interacted with <z:chebi fb="0" ids="50114">estrogen</z:chebi> to alter <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> risk </plain></SENT>
<SENT sid="9" pm="."><plain>Several SNPs in this candidate pathway influenced survival after diagnosis with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (SeP15 and SepX1 increased HRR) and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (SepX1 increased HRR) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Findings support an association between selenoprotein genes and colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> development and survival after diagnosis </plain></SENT>
<SENT sid="11" pm="."><plain>Given the interactions observed, it is likely that the impact of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility from genotype is modified by lifestyle </plain></SENT>
</text></document>